Effects of P-Selectin Antagonist Inclacumab in Patients Undergoing Coronary Artery Bypass Graft Surgery

The recent SELECT-ACS (Effects of the P-Selectin Antagonist Inclacumab on Myocardial Damage After Percutaneous Coronary Intervention for Non-ST-Segment Elevation Myocardial Infarction) trial then demonstrated the efficacy of inclacumab, a human monoclonal antibody directed against P-selectin, in red...

Ausführliche Beschreibung

Bibliographische Detailangaben

Veröffentlicht in:	Journal of the American College of Cardiology 2016, Vol.67 (3), p.344-346
Hauptverfasser:	Stähli, Barbara E., MD, Tardif, Jean-Claude, MD, Carrier, Michel, MD, Gallo, Richard, MD, Emery, Robert W., MD, Robb, Stephen, MD, Cournoyer, Daniel, MSc, Blondeau, Lucie, MSc, Johnson, Dominique, PhD, Mann, Jessica, MD, PhD, Lespérance, Jacques, MD, Guertin, Marie-Claude, PhD, L'Allier, Philippe L., MD
Format:	Artikel
Sprache:	eng
Schlagworte:	Acute coronary syndromes Angioplasty Cardiology Cardiovascular Confidence intervals Coronary vessels Heart attacks Heart surgery Internal Medicine Medical imaging Plasma Veins & arteries
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!